Effect of Sapanisertib (MLN0128) on the QTc Interval in Participants With Advanced Solid Tumors
Clinical trial NCT02197572 · COMPLETED
Trial details
- NCT number
- NCT02197572
- Sponsor
- Calithera Biosciences, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-15
- Primary completion
- 2016-06-10
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.